Literature DB >> 7985824

Surveillance of intravenous catheter-related infections among home care clients.

M C White1, K E Ragland.   

Abstract

BACKGROUND: Infection control in home care is an important area of study, and infection related to home infusion therapy is one component.
METHODS: According to billed supplies from a 6-month period, we identified clients receiving intravenous care and conducted a chart review to determine characteristics and infection status. We reviewed each client from the start of a continuous home care period through April 30, 1992.
RESULTS: Care of the catheters was done by nurses, family care givers, or the clients themselves. Intravenous catheter-related infections-site infections and bacteremia-occurred in three (4.5%) of the sample of 67; bacteremia occurred in one (1.5%). Incidence density was 12.5 infections per 10,000 catheter days (4.2 bacteremias per 10,000 days). Among those with central lines who remained without infection, 22.9% had the same line in place for 90 days or more. Among those with peripheral lines who remained without infection, 14.3% had a peripheral line, which was changed during home care, for 30 days or longer.
CONCLUSIONS: Home care agencies seeking accreditation from the Joint Commission on the Accreditation of Healthcare Organizations need to establish surveillance systems; this may be one method to monitor device-related infections and to determine baseline rates.

Entities:  

Mesh:

Year:  1994        PMID: 7985824     DOI: 10.1016/0196-6553(94)99002-6

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  8 in total

1.  Home intravenous therapy: Accessibility for Canadian children and youth.

Authors:  Dl Moore; R Bortolussi
Journal:  Paediatr Child Health       Date:  2011-02       Impact factor: 2.253

2.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 3.  The prevalence of infections and patient risk factors in home health care: a systematic review.

Authors:  Jingjing Shang; Chenjuan Ma; Lusine Poghosyan; Dawn Dowding; Patricia Stone
Journal:  Am J Infect Control       Date:  2014-03-20       Impact factor: 2.918

4.  Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

5.  Guidelines for the prevention of intravascular catheter-related infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

6.  Environmental Exposures and the Risk of Central Venous Catheter Complications and Readmissions in Home Infusion Therapy Patients.

Authors:  Sara C Keller; Deborah Williams; Mitra Gavgani; David Hirsch; John Adamovich; Dawn Hohl; Amanda Krosche; Sara Cosgrove; Trish M Perl
Journal:  Infect Control Hosp Epidemiol       Date:  2016-10-04       Impact factor: 3.254

7.  Feasibility of national surveillance of health-care-associated infections in home-care settings.

Authors:  Lilia P Manangan; Michele L Pearson; Jerome I Tokars; Elaine Miller; William R Jarvis
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

8.  The adherence to guidelines for preventing CVC-related infections: a survey among Italian health-care workers.

Authors:  Pietro Ferrara; Luciana Albano
Journal:  BMC Infect Dis       Date:  2018-12-03       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.